Last reviewed · How we verify
Multiple-Visit-"Antibiotic Paste" — Competitive Intelligence Brief
marketed
Topical antibiotic paste
Infectious Disease
Small molecule
Live · refreshed every 30 min
Target snapshot
Multiple-Visit-"Antibiotic Paste" (Multiple-Visit-"Antibiotic Paste") — Istanbul Medipol University Hospital. An antibiotic-containing paste formulation that delivers antimicrobial agents directly to a localized site to eliminate bacterial infection.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Multiple-Visit-"Antibiotic Paste" TARGET | Multiple-Visit-"Antibiotic Paste" | Istanbul Medipol University Hospital | marketed | Topical antibiotic paste |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Topical antibiotic paste class)
- Istanbul Medipol University Hospital · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Multiple-Visit-"Antibiotic Paste" CI watch — RSS
- Multiple-Visit-"Antibiotic Paste" CI watch — Atom
- Multiple-Visit-"Antibiotic Paste" CI watch — JSON
- Multiple-Visit-"Antibiotic Paste" alone — RSS
- Whole Topical antibiotic paste class — RSS
Cite this brief
Drug Landscape (2026). Multiple-Visit-"Antibiotic Paste" — Competitive Intelligence Brief. https://druglandscape.com/ci/multiple-visit-antibiotic-paste. Accessed 2026-05-13.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab